Ryan Bitar

Dr. Ryan Bitar

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Radiology
Verified
Journal Article
Closed access
RBRyan Bitar
Ryan Bitar
RSRiad Salem
Riad Salem
RFRichard Finn
Richard Finn
TGTim F. Greten
Tim F. Greten
SGS. Nahum Goldberg
S. Nahum Goldberg
JCJulius Chapiro
Julius Chapiro
This review discusses mechanisms behind the immunosuppressive tumor microenvironment, the influence of locoregional therapy on immunotherapy, and the development of imaging and serologic biomarkers in relation to hepatocellular carcinoma.

14 October 2022 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
COCarlos B. Ortiz
Carlos B. Ortiz
ADAnnie Dang
Annie Dang
KDKade Derrick
Kade Derrick
BOBarrett O’dOnnell
Barrett O’dOnnell
RBRyan Bitar
Ryan Bitar
JLJorge Lopera
Jorge Lopera

29 June 2024 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
RBRyan Bitar
Ryan Bitar
SBSuleyman B. Bozal
Suleyman B. Bozal
ASAnthony Sisti
Anthony Sisti
HMHamid Mojibian
Hamid Mojibian
AMAngelo G. Marino
Angelo G. Marino
JCJoshua Cornman-Homonoff
Joshua Cornman-Homonoff

21 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RBRyan Bitar
Ryan Bitar
Pablo Zurita LozanoPablo Zurita Lozano
Pablo Zurita Lozano
LMLucia Martini
Lucia Martini
AZAmado J Zurita
Amado J Zurita
GRGregory C Ravizzini
Gregory C Ravizzini
Despite substantial improvement in the definitive management of primary prostate cancer, a significant number of patients experience biochemical recurrence—a clinical state in which serum prostate-specific antigen (PSA) levels rise prior to the development of physical signs or symptoms. The early detection and localization of biochemical recurrence may confer eligibility for salvage therapy; therefore, imaging techniques that provide accurate disease visualization are imperative. In this review, we discuss various imaging methods for localizing disease in the context of biochemical recurrence in prostate cancer. Particularly, we describe available or investigational positron emission tomography (PET) radiotracers, such as 18F-FDG, 18F-NaF, choline (both 18F and 11C), the 18F-labeled amino acid derivative fluciclovine, prostate-specific membrane antigen (PSMA) radioligands, and the short peptide compound bombesin. Generally, PET radiotracers such as 18F-FDG, 18F-NaF, and 18F/11C choline have fallen out of favor because of their inferior sensitivity and/or specificity in relation to more recently developed radiotracers. 18F-fluciclovine has addressed these shortcomings by exploiting the upregulation of amino acid transporters in tumors; however, PSMA-targeting agents have significantly advanced the management of biochemical recurrence of prostate cancer through their high sensitivity and specificity, enabling the identification of candidates for radionuclide therapy. Investigational agents, such as bombesin-based radiotracers, may address the shortcomings of treating prostate cancer with little to no PSMA expression.

21 March 2023 in Journal of Vascular Surgery Cases, Innovations and Techniques
Verified
Journal Article
Open access
RBRyan Bitar
Ryan Bitar
OAOluwaseun Ayoade
Oluwaseun Ayoade
AYAnudeep Yekula
Anudeep Yekula
VRVikram Reddy
Vikram Reddy
HPHaddon Pantel
Haddon Pantel
NNNaiem Nassiri
Naiem Nassiri
Rectal venous malformations (VMs) are rare clinical entities with variable patterns of presentation. Treatment requires unique, targeted strategies based on the symptoms, associated complications, and location, depth, and extent of the lesion. We present a rare case of a large, isolated rectal VM treated by direct stick embolization (DSE) using transanal minimally invasive surgery (TAMIS). A 49-year-old man had presented with a rectal mass incidentally detected on computed tomography urography. Magnetic resonance imaging and endoscopy revealed an isolated rectal VM. Elevated D-dimer levels concerning for localized intravascular coagulopathy warranted the use of prophylactic rivaroxaban. To avoid invasive surgery, DSE using TAMIS was performed successfully without complications. His postoperative recovery was uneventful, aside from a self-limiting and expected course of postembolization syndrome. To the best of our knowledge, this is the first reported case of TAMIS-assisted DSE of a colorectal VM. TAMIS shows promise for more widespread use in the minimally invasive, interventional management of colorectal vascular anomalies.

3 March 2025 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
JTJonathan Tefera
Jonathan Tefera
TKTom N. Kuhn
Tom N. Kuhn
NMNickolai J. Matuschewski
Nickolai J. Matuschewski
EMEllen Meister
Ellen Meister
JNJana Nguyenová
Jana Nguyenová
David MadoffDavid Madoff
David Madoff